Detalles de la búsqueda
1.
A Complex Interplay between Notch Effectors and ß-Catenin Signaling in Morular Differentiation of Endometrial Carcinoma Cells.
Am J Pathol;
194(3): 459-470, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096983
2.
Nucleobindin-2 Mediates Transforming Growth Factor-ß1-Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1-High Uterine Carcinosarcoma.
Am J Pathol;
193(8): 1116-1128, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169340
3.
Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma.
BMC Cancer;
23(1): 765, 2023 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592266
4.
Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma.
Am J Pathol;
191(10): 1837-1850, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34214505
5.
Functional interaction between S100A1 and MDM2 may modulate p53 signaling in normal and malignant endometrial cells.
BMC Cancer;
22(1): 184, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177036
6.
A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma.
Cell Commun Signal;
20(1): 46, 2022 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35392912
7.
PTEN overexpression and nuclear ß-catenin stabilization promote morular differentiation through induction of epithelial-mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma.
Cell Commun Signal;
20(1): 181, 2022 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411429
8.
S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma.
Am J Pathol;
190(11): 2304-2316, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32805233
9.
S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.
Lab Invest;
100(5): 682-695, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857700
10.
Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma.
Mol Carcinog;
59(12): 1409-1419, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33111989
11.
Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype.
Cell Commun Signal;
18(1): 103, 2020 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32635925
12.
Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.
BMC Cancer;
19(1): 308, 2019 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30943930
13.
TGF-ß-mediated LEFTY/Akt/GSK-3ß/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas.
Mol Carcinog;
57(8): 957-967, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603383
14.
A functional role of LEFTY during progesterone therapy for endometrial carcinoma.
Cell Commun Signal;
15(1): 56, 2017 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29268772
15.
EBP50 Depletion and Nuclear ß-Catenin Accumulation Engender Aggressive Behavior of Colorectal Carcinoma through Induction of Tumor Budding.
Cancers (Basel);
16(1)2023 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201610
16.
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma.
Mol Oncol;
17(10): 2168-2182, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37539980
17.
A combination of stromal PD-L1 and tumoral nuclear ß-catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma.
J Pathol Clin Res;
8(5): 458-469, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35762092
18.
Immunophenotypic profile as a predictor of prognosis in advanced ovarian carcinoma.
Hum Pathol;
85: 210-220, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30448218
19.
Alterations in ß-catenin, microsatellite instability, and HNF-1ß levels are independently associated with ovarian endometriosis-associated tumorigenesis.
Hum Pathol;
89: 10-23, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022415
20.
Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma.
Oncotarget;
8(38): 63646-63664, 2017 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28969018
Resultados
1 -
20
de 20
1
Próxima >
>>